A detailed history of Focused Investors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Focused Investors LLC holds 1,170,250 shares of JNJ stock, worth $169 Million. This represents 5.88% of its overall portfolio holdings.

Number of Shares
1,170,250
Previous 1,192,150 1.84%
Holding current value
$169 Million
Previous $174 Million 8.84%
% of portfolio
5.88%
Previous 5.72%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$145.48 - $167.38 $3.19 Million - $3.67 Million
-21,900 Reduced 1.84%
1,170,250 $190 Million
Q2 2024

Jul 30, 2024

SELL
$144.38 - $157.78 $4.94 Million - $5.4 Million
-34,200 Reduced 2.79%
1,192,150 $174 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $11.9 Million - $12.4 Million
-76,450 Reduced 5.87%
1,226,350 $194 Million
Q4 2023

Jan 25, 2024

SELL
$145.6 - $158.88 $1.05 Million - $1.14 Million
-7,200 Reduced 0.55%
1,302,800 $204 Million
Q3 2023

Oct 19, 2023

SELL
$155.75 - $174.48 $3.43 Million - $3.84 Million
-22,000 Reduced 1.65%
1,310,000 $204 Million
Q2 2023

Jul 25, 2023

SELL
$154.35 - $166.11 $995,557 - $1.07 Million
-6,450 Reduced 0.48%
1,332,000 $220 Million
Q1 2023

Apr 26, 2023

SELL
$151.05 - $180.26 $9.49 Million - $11.3 Million
-62,800 Reduced 4.48%
1,338,450 $207 Million
Q4 2022

Jan 25, 2023

SELL
$160.2 - $179.79 $2.15 Million - $2.41 Million
-13,400 Reduced 0.95%
1,401,250 $248 Million
Q3 2022

Oct 14, 2022

SELL
$161.33 - $179.52 $3.48 Million - $3.87 Million
-21,550 Reduced 1.5%
1,414,650 $231 Million
Q2 2022

Aug 01, 2022

SELL
$168.19 - $186.01 $302,742 - $334,818
-1,800 Reduced 0.13%
1,436,200 $255 Million
Q1 2022

Apr 20, 2022

SELL
$158.14 - $179.59 $6.36 Million - $7.22 Million
-40,200 Reduced 2.72%
1,438,000 $255 Million
Q4 2021

Feb 07, 2022

BUY
$155.93 - $173.01 $15.2 Million - $16.9 Million
97,400 Added 7.05%
1,478,200 $253 Million
Q3 2021

Oct 27, 2021

SELL
$161.5 - $179.47 $8.19 Million - $9.1 Million
-50,700 Reduced 3.54%
1,380,800 $223 Million
Q2 2021

Aug 03, 2021

BUY
$159.48 - $171.07 $6.67 Million - $7.15 Million
41,800 Added 3.01%
1,431,500 $236 Million
Q1 2021

Apr 26, 2021

BUY
$153.07 - $170.48 $15.6 Million - $17.4 Million
102,000 Added 7.92%
1,389,700 $228 Million
Q4 2020

Jan 22, 2021

SELL
$137.11 - $157.38 $1.38 Million - $1.59 Million
-10,100 Reduced 0.78%
1,287,700 $203 Million
Q3 2020

Oct 21, 2020

SELL
$140.38 - $153.83 $4.89 Million - $5.35 Million
-34,800 Reduced 2.61%
1,297,800 $193 Million
Q2 2020

Jul 23, 2020

SELL
$128.81 - $155.51 $1.29 Million - $1.56 Million
-10,000 Reduced 0.74%
1,332,600 $187 Million
Q1 2020

Apr 23, 2020

BUY
$111.14 - $153.99 $17.3 Million - $23.9 Million
155,500 Added 13.1%
1,342,600 $176 Million
Q4 2019

Jan 23, 2020

BUY
$127.5 - $146.44 $8.95 Million - $10.3 Million
70,200 Added 6.29%
1,187,100 $173 Million
Q3 2019

Oct 21, 2019

SELL
$126.95 - $142.14 $647,445 - $724,913
-5,100 Reduced 0.45%
1,116,900 $145 Million
Q2 2019

Jul 16, 2019

BUY
$131.15 - $144.24 $1.14 Million - $1.25 Million
8,700 Added 0.78%
1,122,000 $156 Million
Q1 2019

Apr 16, 2019

SELL
$125.72 - $139.79 $4.5 Million - $5 Million
-35,800 Reduced 3.12%
1,113,300 $156 Million
Q4 2018

Jan 25, 2019

SELL
$122.84 - $147.84 $6.17 Million - $7.42 Million
-50,200 Reduced 4.19%
1,149,100 $148 Million
Q3 2018

Oct 19, 2018

SELL
$121.58 - $142.88 $851,060 - $1 Million
-7,000 Reduced 0.58%
1,199,300 $166 Million
Q2 2018

Jul 24, 2018

BUY
$119.4 - $131.76 $8.26 Million - $9.12 Million
69,200 Added 6.09%
1,206,300 $146 Million
Q1 2018

Apr 20, 2018

BUY
$125.1 - $148.14 $5.89 Million - $6.98 Million
47,100 Added 4.32%
1,137,100 $146 Million
Q4 2017

Jan 23, 2018

BUY
$131.22 - $143.62 $11.1 Million - $12.1 Million
84,400 Added 8.39%
1,090,000 $152 Million
Q3 2017

Oct 19, 2017

BUY
$129.47 - $135.38 $130 Million - $136 Million
1,005,600
1,005,600 $131 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Focused Investors LLC Portfolio

Follow Focused Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Focused Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Focused Investors LLC with notifications on news.